Inhibition of XO by febuxostat was associated with suppression of VEGF/VEGFR1 and VEGFR3 axis and subsequent Akt phosphorylation, which resulted in attenuation of endothelial dysfunction in DKD mice and HG-induced human GECs. This evidence concerns the gene VEGFA and diabetic kidney disease.